Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom? | ASCO Daily News
Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures | Radiation Oncology | Full Text
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma - ScienceDirect
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed | Nature Reviews Clinical Oncology
Comparison of disease-free survival (DFS) and overall survival (OS)... | Download Scientific Diagram
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology
Cancers | Free Full-Text | Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Progression-free survival and overall survival curves for all patients... | Download Scientific Diagram
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | The Patient - Patient-Centered Outcomes Research
Cancers | Free Full-Text | Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
Disease Free Survival - an overview | ScienceDirect Topics
Comparison Overall survival and Disease free survival graph between two... | Download Scientific Diagram
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom? | ASCO Daily News
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Extrapolation from Progression Free Survival to Overall Survival in Oncology | PPT
Kaplan-Meier Estimates of Recurrence-free Survival and Overall... | Download Scientific Diagram
Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study | Breast Cancer Research and Treatment
Progression-free survival and overall survival. Progression-free... | Download Scientific Diagram
Overall survival (a) and disease-free survival (b) among the entire... | Download Scientific Diagram
